The Enrichment Program supports the overall mission of the Penn DRC to prevent, treat, and cure diabetes. Its goals are to ensure that the DRC investigators from different departments and locations interact frequently and productively, that new scientific knowledge related to diabetes is disseminated to DRC investigators, and that the importance of diabetes research is recognized in the Philadelphia area. To achieve these goals, the Enrichment Program has the following Specific Aims; 1. Disseminate new diabetes research knowledge; 2) Foster interactions among DRC investigators; 3) Catalyze interdisciplinary interactions; 4) Foster the next generation of diabetes researchers; and 5) Increase awareness of the Penn DRC and the importance of diabetes research. The high scientific quality of the Enrichment Program's activities attracts not only Penn DRC members, but other members of the research community to lectures and events that increase awareness of Penn DRC cores and diabetes research. In addition, lay-oriented community events are hosted and designed to educate the public about the devastating epidemic of diabetes, and the importance of diabetes research at the Penn DRC and elsewhere to preventing and curing these diseases. In sum, the Enrichment Program of the Penn DRC plays a vital role in advancing the exchange of knowledge about diabetes, catalyzing interdisciplinary interactions and research in the scientific community it serves, and enhancing awareness of exciting diabetes research aimed at a cure at a time when the disease is rampant and increasingly threatening the health of people in Philadelphia and across the United States.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK019525-39
Application #
8902119
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
2016-03-31
Budget Start
2015-04-01
Budget End
2016-03-31
Support Year
39
Fiscal Year
2015
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Wangensteen, Kirk J; Wang, Yue J; Dou, Zhixun et al. (2018) Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform. Hepatology 68:663-676
Brown, Justin C; Damjanov, Nevena; Courneya, Kerry S et al. (2018) A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivors. Psychooncology 27:1221-1228
Wooldridge, Amy L; Bischof, Robert J; Liu, Hong et al. (2018) Late-gestation maternal dietary methyl donor and cofactor supplementation in sheep partially reverses protection against allergic sensitization by IUGR. Am J Physiol Regul Integr Comp Physiol 314:R22-R33
Kim, Boa; Jang, Cholsoon; Dharaneeswaran, Harita et al. (2018) Endothelial pyruvate kinase M2 maintains vascular integrity. J Clin Invest 128:4543-4556
Gibson, Christopher E; Boodhansingh, Kara E; Li, Changhong et al. (2018) Congenital Hyperinsulinism in Infants with Turner Syndrome: Possible Association with Monosomy X and KDM6A Haploinsufficiency. Horm Res Paediatr 89:413-422
Hill, David A; Lim, Hee-Woong; Kim, Yong Hoon et al. (2018) Distinct macrophage populations direct inflammatory versus physiological changes in adipose tissue. Proc Natl Acad Sci U S A 115:E5096-E5105
Kim, Yong Hoon; Marhon, Sajid A; Zhang, Yuxiang et al. (2018) Rev-erb? dynamically modulates chromatin looping to control circadian gene transcription. Science 359:1274-1277
Mowel, Walter K; Kotzin, Jonathan J; McCright, Sam J et al. (2018) Control of Immune Cell Homeostasis and Function by lncRNAs. Trends Immunol 39:55-69
Rickels, Michael R; Peleckis, Amy J; Dalton-Bakes, Cornelia et al. (2018) Continuous Glucose Monitoring for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes. J Clin Endocrinol Metab 103:105-114
Guan, Dongyin; Xiong, Ying; Borck, Patricia C et al. (2018) Diet-Induced Circadian Enhancer Remodeling Synchronizes Opposing Hepatic Lipid Metabolic Processes. Cell 174:831-842.e12

Showing the most recent 10 out of 720 publications